New Jersey S 1126: Prohibits bio-analytical laboratories from charging certain patients more than 115% of the applicable Medicare rate.

Status: Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee (as of 2020-01-30)

State: New Jersey · Session: 219 · Bill: S 1126

Subjects: HEALTH INSUR, MEDICAID

Sponsors: Vitale, Joseph F.

View New Jersey S 1126 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.